Top analyst sets outrageous Intel stock target ahead of earnings
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy?
Key PointsAxsome Therapeutics' revenue is growing at a good clip.
3 Dividend Stocks to Buy and Hold for 10 Years
Key PointsPfizer has a deep pipeline that could help improve its approved lineup and financial results over the medium term.
Colombia’s Peso Rally Is Driven by Strong Inflows, Election-Driven Confidence and Rate Differentials
The Colombian peso has appreciated almost 23% against the U.S. dollar in 2026, reversing much of the sharp depreciation that pushed the exchange rate almost 5,000 pesos per dollar in late 2022.